Our thanks to all the campaigners below who have helped raise funds for Hepatitis B Foundation.
Four runners have received Appreciation Awards for supporting Hepatitis B Foundation UK.
NICE has announced that Baraclude® (entecavir) is recommended as an option for treatment of eligible patients with chronic hepatitis B.
It's still not too late to support Team Hepatitis B Foundation UK!
We need critical readers to review the draft leaflet and give comments.
We need people to join our Patients' Advisory Group.